Abstract:Dermal fibroblasts (dFBs) defend against deep bacterial skin infections by differentiating into preadipocytes (pAds) that produce the antimicrobial peptide cathelicidin; this differentiation is known as the dermal reactive adipogenesis response. However, the role of dFBs in fungal infection remains unknown. Here, we found that cathelicidin-producing pAds were present in high numbers in skin lesions from patients with cutaneous Candida granulomas. Second, we showed that dermal Candida albicans ( C . albicans ) infection in mice robustly triggered the dermal reactive adipogenesis response and induced cathelicidin expression, and inhibition of adipogenesis with pharmacological inhibitors of peroxisome proliferator–activated receptor γ (PPARγ) impaired skin resistance to C . albicans . In vitro , C . albicans products induced cathelicidin expression in pAds, and differentiating pAds markedly suppressed the growth of C . albicans by producing cathelicidin. Finally, we showed that C . albicans induced an antimicrobial response in pAds through the FGFR-MEK-ERK pathway. Together, our data reveal a previously unknown role of dFBs in the defense against skin infection caused by C . albicans . Candida albicans ( C . albicans ) is the pathogen that most commonly causes human fungal infections. It normally inhabits the skin surface, genital and/or intestinal mucosa of almost 30–70% healthy individuals. In certain instances, such as impairment of skin barrier integrity or immunosuppression, C . albicans can cause mucosal and cutaneous candidiasis. Here, we demonstrated the protective role of dermal fibroblasts against C . albicans skin infection, which is previously unknown. Firstly, we found that the number of cathelicidin-producing preadipocytes (pAds) increased in both human and mouse skin lesions infected with C . albicans , indicating that C . albicans infection triggers a dermal reactive adipogenesis response. Furthermore, we found inhibiting adipogenesis by administration of pharmacological inhibitors of peroxisome proliferator–activated receptor γ, or suppressing cathelicidin expression, impaired skin resistance to C . albicans . Finally, we showed that pAds produced cathelicidin through the FGFR-MEK-ERK pathway in response to C . albicans infection. Our results could provide new therapeutic strategies for the treatment of deep cutaneous candidiasis.

Protection Against Epithelial Damage During Candida albicans Infection Is Mediated by PI3K/Akt and Mammalian Target of Rapamycin Signaling

Receptor-kinase EGFR-MAPK adaptor proteins mediate the epithelial response to Candida albicans via the cytolytic peptide toxin, candidalysin

EGR1 regulates oral epithelial cell responses to Candida albicans via the EGFR- ERK1/2 pathway

Divergent EGFR/MAPK-Mediated Immune Responses to Clinical Candida Pathogens in Vulvovaginal Candidiasis

Immunity to pathogenic mucosal C. albicans infections mediated by oral megakaryocytes activated by IL-17 and candidalysin

Breaking barriers: the fungal toxin candidalysin disrupts epithelial integrity and induces inflammation in a gut-on-chip model

Calcium-dependent ESCRT recruitment and lysosome exocytosis maintain epithelial integrity during Candida albicans invasion

Activation of ERK-FAK Signaling Pathway and Enhancement of Cell Migration Involved in the Early Interaction Between Oral Keratinocytes and Candida Albicans

Abolishing Cell Wall Glycosylphosphatidylinositol-Anchored Proteins in Candida Albicans Enhances Recognition by Host Dectin-1.

Multiple roles and diverse regulation of the Ras/cAMP/protein kinase A pathway in Candida albicans

Non-canonical IL-22 receptor signaling remodels the mucosal barrier during fungal immunosurveillance

Epithelial Cells Attenuate Toll-Like Receptor-Mediated Inflammatory Responses in Monocyte-Derived Macrophage-Like Cells to Mycobacterium Tuberculosis by Modulating the PI3K/Akt/mTOR Signaling Pathway.

Candida Albicans Infection Disturbs the Redox Homeostasis System and Induces Reactive Oxygen Species Accumulation for Epithelial Cell Death

A genome-scale screen identifies sulfated glycosaminoglycans as pivotal in epithelial cell damage by Candida albicans

Candidalysin, a Virulence Factor of Candida albicans, Stimulates Mast Cells by Mediating Cross-Talk Between Signaling Pathways Activated by the Dectin-1 Receptor and MAPKs

Comparative Analysis of Inflammatory Cytokine Release and Alveolar Epithelial Barrier Invasion in a Transwell® Bilayer Model of Mucormycosis

Different Host Immunological Response to C. Albicans by Human Oral and Vaginal Epithelial Cells

AIM2 enhances Candida albicans infection through promoting macrophage apoptosis via AKT signaling

Advances in TOR pathway in Candida albicans

Role of Bacterial Lipopolysaccharide in Enhancing Host Immune Response Tocandida Albicans

Antimicrobial peptide-producing dermal preadipocytes defend against Candida albicans skin infection via the FGFR-MEK-ERK pathway